Kuangli Bio-Tech Holdings Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jing-Xiang Lin
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 6.5yrs |
Recent management updates
Recent updates
Kuangli Bio-Tech Holdings Co., Ltd. (TWSE:6431) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Feb 25
Kuangli Bio-Tech Holdings Co., Ltd.'s (TWSE:6431) Shareholders Might Be Looking For Exit
Mar 22We're Not Worried About Kuangli Photoelectric Technology's (TPE:6431) Cash Burn
Mar 31Did Business Growth Power Kuangli Photoelectric Technology's (TPE:6431) Share Price Gain of 248%?
Feb 03
We Think Kuangli Photoelectric Technology (TPE:6431) Can Easily Afford To Drive Business Growth
Dec 09CEO
Jing-Xiang Lin
Jing-Xiang Lin is President of Kuangli Bio-Tech Holdings Co. Ltd. from May 29, 2025.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Manager & Director | 6.5yrs | no data | 1.41% NT$ 21.9m | |
| Independent Director | no data | no data | no data | |
| Independent Director | 6.5yrs | no data | no data | |
| Director | 6.5yrs | no data | no data | |
| Director | 6.5yrs | no data | no data | |
| Independent Director | 6.5yrs | no data | no data | |
| Director | no data | no data | no data | |
| Representative Director | no data | no data | 0% NT$ 0 | |
| Representative Chairman | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
Experienced Board: 6431's board of directors are considered experienced (6.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/13 08:43 |
| End of Day Share Price | 2025/10/13 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kuangli Bio-Tech Holdings Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.